Skip to content
Recall Observatory FDA recall evidence

Drug product

chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1

D-0361-2025

April 03, 2025

Class II

Product summary

Firm
Zydus Pharmaceuticals (USA) Inc
Event
Event 96626
Status
Ongoing
Classification
Class II
Quantity
3144 bottles, pack size: 100's Count
Official record key
drug-enforcement:D-0361-2025

Official wording

Reason: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Code information: Lot #: Z400069, Exp.: 12/31/2025

Distribution pattern: Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-Nitroso-Desmethyl Chlorpromazine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP deviations